A citation-based method for searching scientific literature

Sandra Cuerpo, Jorge Moisés, Fernanda Hernández-González, Mariana Benegas, Jose Ramirez, Marcelo Sánchez, Àlvar Agustí, Jacobo Sellares. Chron Respir Dis 2019
Times Cited: 5







List of co-cited articles
17 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome.
J W Song, S-B Hong, C-M Lim, Y Koh, D S Kim. Eur Respir J 2011
453
60

Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm.
Christopher J Ryerson, Vincent Cottin, Kevin K Brown, Harold R Collard. Eur Respir J 2015
97
60

Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
Jean-Marc Naccache, Melissa Montil, Jacques Cadranel, Marine Cachanado, Vincent Cottin, Bruno Crestani, Dominique Valeyre, Benoit Wallaert, Tabassome Simon, Hilario Nunes. BMC Pulm Med 2019
12
40

Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.
Hironao Hozumi, Hirotsugu Hasegawa, Koichi Miyashita, Hideki Yasui, Yuzo Suzuki, Masato Kono, Masato Karayama, Kazuki Furuhashi, Dai Hashimoto, Noriyuki Enomoto,[...]. Respirology 2019
12
40

Exacerbations of idiopathic pulmonary fibrosis treated with corticosteroids and cyclophosphamide pulses.
E Morawiec, I Tillie-Leblond, V Pansini, J Salleron, M Remy-Jardin, B Wallaert. Eur Respir J 2011
41
40

Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study.
Kenji Tsushima, Koichi Yamaguchi, Yuta Kono, Toshiki Yokoyama, Keishi Kubo, Takuma Matsumura, Yasunori Ichimura, Mitsuhiro Abe, Jiro Terada, Koichiro Tatsumi. Pulm Pharmacol Ther 2014
50
40

Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: A historically controlled study.
Susumu Sakamoto, Hiroshige Shimizu, Takuma Isshiki, Keishi Sugino, Atsuko Kurosaki, Sakae Homma. Respir Investig 2018
21
40

Acute exacerbations of idiopathic pulmonary fibrosis.
Harold R Collard, Bethany B Moore, Kevin R Flaherty, Kevin K Brown, Robert J Kaner, Talmadge E King, Joseph A Lasky, James E Loyd, Imre Noth, Mitchell A Olman,[...]. Am J Respir Crit Care Med 2007
754
40


Corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: a single center experience and literature review.
Luca Novelli, Roberto Ruggiero, Federica De Giacomi, Alice Biffi, Paola Faverio, Luca Bilucaglia, Silvia Gamberini, Grazia Messinesi, Alberto Pesci. Sarcoidosis Vasc Diffuse Lung Dis 2016
21
40

Recombinant Human Thrombomodulin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
Kensuke Kataoka, Hiroyuki Taniguchi, Yasuhiro Kondoh, Osamu Nishiyama, Tomoki Kimura, Toshiaki Matsuda, Toshiki Yokoyama, Koji Sakamoto, Masahiko Ando. Chest 2015
81
40

Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.
Harold R Collard, Christopher J Ryerson, Tamera J Corte, Gisli Jenkins, Yasuhiro Kondoh, David J Lederer, Joyce S Lee, Toby M Maher, Athol U Wells, Katerina M Antoniou,[...]. Am J Respir Crit Care Med 2016
612
40

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
40

Recombinant human soluble thrombomodulin treatment for acute exacerbation of idiopathic pulmonary fibrosis: a retrospective study.
Takuma Isshiki, Susumu Sakamoto, Arisa Kinoshita, Keishi Sugino, Atsuko Kurosaki, Sakae Homma. Respiration 2015
51
40


Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis.
I-Nae Park, Dong Soon Kim, Tae Sun Shim, Chae-Man Lim, Sang Do Lee, Younsuck Koh, Woo Sung Kim, Won Dong Kim, Se Jin Jang, Thomas V Colby. Chest 2007
219
40

Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Hayley Barnes, Anne E Holland, Glen P Westall, Nicole Sl Goh, Ian N Glaspole. Cochrane Database Syst Rev 2018
54
40


Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis.
Shinichiro Ohshimo, Nobuhisa Ishikawa, Yasushi Horimasu, Noboru Hattori, Nobuyuki Hirohashi, Koichi Tanigawa, Nobuoki Kohno, Francesco Bonella, Josune Guzman, Ulrich Costabel. Respir Med 2014
111
20

High-dose prednisolone after intravenous methylprednisolone improves prognosis of acute exacerbation in idiopathic interstitial pneumonias.
Toru Arai, Kazunobu Tachibana, Chikatoshi Sugimoto, Yasushi Inoue, Sayoko Tokura, Tomohisa Okuma, Masanori Akira, Masanori Kitaichi, Seiji Hayashi, Yoshikazu Inoue. Respirology 2017
25
20



Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis.
Harold R Collard, Luca Richeldi, Dong Soon Kim, Hiroyuki Taniguchi, Inga Tschoepe, Maurizio Luisetti, Jesse Roman, Gregory Tino, Rozsa Schlenker-Herceg, Christoph Hallmann,[...]. Eur Respir J 2017
78
20

Idiopathic Pulmonary Fibrosis.
David J Lederer, Fernando J Martinez. N Engl J Med 2018
601
20

Survival from an Acute Exacerbation of Idiopathic Pulmonary Fibrosis with or without Direct Hemoperfusion with a Polymyxin B-immobilized Fiber Column: A Retrospective Analysis.
Keiji Oishi, Keisuke Aoe, Yusuke Mimura, Yoriyuki Murata, Kenji Sakamoto, Wataru Koutoku, Tsuneo Matsumoto, Hiroshi Ueoka, Masafumi Yano. Intern Med 2016
26
20

The increasing mortality of idiopathic pulmonary fibrosis: fact or fallacy?
Christopher J Ryerson, Martin Kolb. Eur Respir J 2018
22
20

Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis.
J S Lee, J W Song, P J Wolters, B M Elicker, T E King, D S Kim, H R Collard. Eur Respir J 2012
140
20


Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
20

Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF.
Erica Farrand, Eric Vittinghoff, Brett Ley, Atul J Butte, Harold R Collard. Respirology 2020
27
20

Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis.
Yasuhiro Kondoh, Vincent Cottin, Kevin K Brown. Eur Respir Rev 2017
41
20

Baseline High-Resolution CT Findings Predict Acute Exacerbation of Idiopathic Pulmonary Fibrosis: German and Japanese Cohort Study.
Chihiro Hirano, Shinichiro Ohshimo, Yasushi Horimasu, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Nobuoki Kohno, Daisuke Komoto, Kazuo Awai, Nobuaki Shime,[...]. J Clin Med 2019
4
25

Association between cytokine removal by polymyxin B hemoperfusion and improved pulmonary oxygenation in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Keiji Oishi, Yuka Mimura-Kimura, Taku Miyasho, Keisuke Aoe, Yoshiko Ogata, Hideki Katayama, Yoriyuki Murata, Hiroshi Ueoka, Tsuneo Matsumoto, Yusuke Mimura. Cytokine 2013
55
20

Risk factors for acute exacerbation of idiopathic pulmonary fibrosis--Extended analysis of pirfenidone trial in Japan.
Yasuhiro Kondoh, Hiroyuki Taniguchi, Masahito Ebina, Arata Azuma, Takashi Ogura, Yoshio Taguchi, Moritaka Suga, Hiroki Takahashi, Koichiro Nakata, Yukihiko Sugiyama,[...]. Respir Investig 2015
38
20

Thrombomodulin and its role in inflammation.
Edward M Conway. Semin Immunopathol 2012
198
20

Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.
Joyce S Lee, Harold R Collard, Kevin J Anstrom, Fernando J Martinez, Imre Noth, Rhonda S Roberts, Eric Yow, Ganesh Raghu. Lancet Respir Med 2013
255
20

High-resolution CT of complications of idiopathic fibrotic lung disease.
C R Lloyd, S L F Walsh, D M Hansell. Br J Radiol 2011
20
20

Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences.
Motoki Natsuizaka, Hirofumi Chiba, Koji Kuronuma, Mitsuo Otsuka, Kazumi Kudo, Mitsuru Mori, Masashi Bando, Yukihiko Sugiyama, Hiroki Takahashi. Am J Respir Crit Care Med 2014
245
20

Immune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis.
Elisabetta Balestro, Fiorella Calabrese, Graziella Turato, Francesca Lunardi, Erica Bazzan, Giuseppe Marulli, Davide Biondini, Emanuela Rossi, Alessandro Sanduzzi, Federico Rea,[...]. PLoS One 2016
63
20

Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS.
Ulrich Costabel, Yoshikazu Inoue, Luca Richeldi, Harold R Collard, Inga Tschoepe, Susanne Stowasser, Arata Azuma. Am J Respir Crit Care Med 2016
161
20

Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features.
D S Kim, J H Park, B K Park, J S Lee, A G Nicholson, T Colby. Eur Respir J 2006
317
20

Direct hemoperfusion using immobilized polymyxin B in patients with rapidly progressive interstitial pneumonias: a retrospective study.
Shintaro Hara, Hiroshi Ishimoto, Noriho Sakamoto, Hiroshi Mukae, Tomoyuki Kakugawa, Yuji Ishimatsu, Mariko Mine, Shigeru Kohno. Respiration 2011
39
20

Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume.
Martin Kolb, Luca Richeldi, Jürgen Behr, Toby M Maher, Wenbo Tang, Susanne Stowasser, Christoph Hallmann, Roland M du Bois. Thorax 2017
130
20

Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis.
Ryo Teramachi, Yasuhiro Kondoh, Kensuke Kataoka, Hiroyuki Taniguchi, Toshiaki Matsuda, Tomoki Kimura, Toshiki Yokoyama, Yasuhiko Yamano, Taiki Furukawa, Koji Sakamoto,[...]. Respir Med 2018
12
20

Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis.
Masanori Akira, Takenori Kozuka, Satoru Yamamoto, Mitsunori Sakatani. Am J Respir Crit Care Med 2008
132
20

Beneficial effect of polymyxin B-immobilized fiber column (PMX) hemoperfusion treatment on acute exacerbation of idiopathic pulmonary fibrosis.
Yoshitsugu Seo, Shinji Abe, Misuzu Kurahara, Daisuke Okada, Yoshinobu Saito, Jiro Usuki, Arata Azuma, Kiyoshi Koizumi, Shoji Kudoh. Intern Med 2006
59
20

Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses.
Rehan A Kahloon, Jianmin Xue, Arpit Bhargava, Eva Csizmadia, Leo Otterbein, Daniel J Kass, Jessica Bon, Makoto Soejima, Marc C Levesque, Kathleen O Lindell,[...]. Am J Respir Crit Care Med 2013
122
20

Survival in Idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach.
Spyros A Papiris, Konstantinos Kagouridis, Likurgos Kolilekas, Andriana I Papaioannou, Aneza Roussou, Christina Triantafillidou, Katerina Baou, Katerina Malagari, Stylianos Argentos, Anastasia Kotanidou,[...]. BMC Pulm Med 2015
46
20

Opioids: an unexplored option for treatment of dyspnea in IPF.
Charlotte Kohberg, Charlotte Uggerhøj Andersen, Elisabeth Bendstrup. Eur Clin Respir J 2016
38
20



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.